# Pathological evaluation of a fluoropolymer-based drug-eluting stent in an arteriovenous graft outflow venous stenosis

**Authors:** Kotaro Suemitsu, Osamu Iida, Sho Torii, Yosuke Hata, Taku Toyoshima, Masaaki Izumi

PMC · DOI: 10.1016/j.jvscit.2024.101447 · Journal of Vascular Surgery Cases, Innovations and Techniques · 2024-02-08

## TL;DR

A drug-eluting stent made of fluoropolymer was implanted in a vein graft, and after two and a half years, it was removed and examined.

## Contribution

The study provides pathological insights into the long-term performance of a fluoropolymer-based drug-eluting stent in venous stenosis.

## Key findings

- The stent struts showed partial endothelial cell coverage.
- The remaining stent surface was mostly covered by fibrin.
- No restenosis or aneurysmal changes were observed.

## Abstract

A fluoropolymer-based drug-eluting stent was implanted in an arteriovenous graft outflow venous stenosis. Two and a half years later, due to a local infection, the stent was removed surgically, and a pathological evaluation was conducted. The stent struts exhibited partial endothelial cell coverage, with the remaining surface predominantly covered by fibrin. Notably, there was no evidence of restenosis or aneurysmal change.

## Full-text entities

- **Diseases:** aneurysmal change (MESH:D000783), restenosis (MESH:D023903), arteriovenous graft outflow venous stenosis (MESH:D006502), infection (MESH:D007239)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC10950806/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC10950806/full.md

## References

12 references — full list in the complete paper: https://tomesphere.com/paper/PMC10950806/full.md

---
Source: https://tomesphere.com/paper/PMC10950806